Stem Cell Therapy Market By Treatment Mode (Autologous And Allogeneic), By Therapeutic Application (CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye And Immune System)-Global Forecasts To 2020
This report covers definition, description, and forecast for the Global “Stem Cell Therapy market”. It involves detailed analysis of the market segmentation, which comprises treatment mode and therapeutic applications. This market is expected to grow at a CAGR of 32.1% in the forecasted period of 2015 to 2020. The report also provides the strategic analysis of the key players in this market. Based on treatment mode, the stem cell therapy market is segmented into autologous stem cell therapy and allogeneic stem cell therapy, wherein autologous stem cell therapy segment dominated the market registering the market share of 90.0% in 2014. Therapeutic application based market is further categorized into CNS, CVS, GIT, wound healing, musculoskeletal, eye and immune system. Where the immune system diseases segment dominated the market with the highest market share in 2014.
Growing demand for stem cell therapy market is due to number of factors such as increasing focus on human embryonic system cells, increasing approvals of clinical trials for stem cell therapy, development of advanced genomic methods for stem cell analysis, increasing funding for new stem cell lines and others.
Embryonic stem cells play a major role in stem cell therapy as these cells are pluripotent in nature, that is, these cells can give rise to all type of cells that make the entire human body. In the year 2013, NIH granted approximately $146 million for research on human embryonic stem cells. These grants aimed at funding a variety of research projects which were into developing cells that can be utilized to treat heart and nervous system diseases. Also in the same year, Japanese government granted a funding of $1.12 billion to various projects which were aimed at studying embryonic stem cells and their harvesting.
Stem cell therapies are effective in treating various incurable diseases, including cancer, heart disease, multiple sclerosis, spinal cord injuries, strokes, and severe head injuries. Thus, once commercialized, stem cell-based therapies may prove to be effective therapeutic alternatives for treating incurable ailments. Increasing approvals of clinical trials for novel stem cell therapies boosts various manufacturers to venture into this industry.
The report also provides a detailed competitive landscaping of Companies operating in this market. Segment and Country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies would be detailed. The key players operating in this market are Mesoblast Ltd. (Australia), Aastrom Biosciences Inc. (U.S.), Celgene Corporation (U.S.), and StemCell Inc. (Canada), Pluristem Therapeutics (Israel), Cytori Therapeutics (U.S.), Advanced Cell Technologies (U.S.), Athersys Inc. (U.S.), and Aastrom Biosciences Inc. (U.S.) among others.
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement